2 results
Comparing the Application of CEA and BCA to Tuberculosis Control Interventions in South Africa
- Thomas Wilkinson, Fiammetta Bozzani, Anna Vassall, Michelle Remme, Edina Sinanovic
-
- Journal:
- Journal of Benefit-Cost Analysis / Volume 10 / Issue S1 / Spring 2019
- Published online by Cambridge University Press:
- 08 March 2019, pp. 132-153
-
- Article
-
- You have access Access
- Open access
- HTML
- Export citation
-
Achieving ambitious targets to address the global tuberculosis (TB) epidemic requires consideration of the impact of competing interventions for improved identification of patients with TB. Cost-effectiveness analysis (CEA) and benefit-cost analysis (BCA) are two approaches to economic evaluation that assess the costs and effects of competing alternatives. However, the differing theoretical basis and methodological approach to CEA and BCA is likely to result in alternative analytical outputs and potentially different policy interpretations. A BCA was conducted by converting an existing CEA on various combinations of TB control interventions in South Africa using a benefits transfer approach to estimate the value of statistical life (VSL) and value of statistical life year (VSLY). All combinations of interventions reduced untreated active disease compared to current TB control, reducing deaths by between 5,000 and 75,000 and resulting in net benefits of Int$3.2–Int$137 billion (ZAR18.1 billion to ZAR764 billion) over a 20-year period. This analysis contributes to development and application of BCA methods for health interventions and demonstrates that further investment in TB control in South Africa is expected to yield significant benefits. Further work is required to guide the appropriate analytical approach, interpretation and policy recommendations in the South African policy perspective and context.
5 - Social policy
- Edited by Bjørn Lomborg, Copenhagen Business School
-
- Book:
- RethinkHIV
- Published online:
- 05 November 2012
- Print publication:
- 18 October 2012, pp 238-298
-
- Chapter
- Export citation
-
Summary
The HIV/AIDS epidemic is now in its thirtieth year. Over the past decade remarkable progress in addressing the consequences of HIV has been made, with nearly five million people on anti-retroviral treatment. However, prevention efforts have been less successful: globally there are approximately 7,000 infections daily, with the numbers of newly infected outnumbering those newly being put on treatment. Sub-Saharan Africa continues to bear the brunt of the HIV epidemic, with HIV prevalence rates of up to 26 percent in some countries (UNAIDS 2010a). Despite these challenges, there are also marked successes, with declines in rates of new HIV infections in many regions globally, including in sub-Saharan Africa. These declines are likely to be the result of large-scale HIV prevention efforts, as well as more fundamental changes in sexual behavior that have evolved as communities respond to the realities of the HIV epidemic and the toll that it is taking.
In sub-Saharan Africa, HIV transmission is largely heterosexual, although the role of transmission among men who have sex with men, and among injecting drug users, is also starting to be acknowledged. Established responses to addressing the heterosexual transmission of HIV include behavioral change communication programs, interventions focused on key at-risk populations (such as sex workers and their clients), male circumcision, HIV testing and counseling, condom promotion, and the treatment of sexually transmitted infections. Some of these interventions have been considered in other RethinkHIV papers, and are likely to remain central to a comprehensive HIV response. Although RethinkHIV focuses on sub-Saharan Africa in its entirety, the epidemic varies considerably by setting. In practice the optimal mix of interventions implemented in any setting will vary, and be influenced by the extent to which, at a population level, HIV infection is largely concentrated amongst vulnerable groups such as sex workers, men who have sex with men, or injecting drug users (a concentrated HIV epidemic), or more widely generalized in the population (a generalized HIV epidemic).